United States· US:0527-1791_59cf1ea7-b827-4780-bf94-cd3446d6dcc3
Fluphenazine Hydrochloride
A fluphenazine product containing fluphenazine hydrochloride, registered in United States by Lannett Company, Inc.. The same ATC class is registered in 7 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Fluphenazine is registered in 7 of 19 countries.
Countries holding a registration under ATC N05AB02 (fluphenazine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Fluphenazine · ATC N05AB02
7 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FLUPHENAZINE HYDROCHLORIDE
- Manufacturer
- Lannett Company, Inc.
- Country
- United States (US)
- ATC code
- N05AB02
- ATC class
- Fluphenazine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc110527179101100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-1791-01)
- ndc110527179105500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-1791-05)
- ndc110527-1791-01
- ndc110527-1791-05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
425 interactions on record for fluphenazine.
Graded by severity as the source publishes them — 51 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fluphenazine · interactions on record
425 records
- 51 severe
- 329 moderate
- 10 minor
- 11 info
Most severe, free to view
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Potassium chlorideA12BA01severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fluphenazine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayFluphenazin-neuraxpharm DNeuraxpharm
- FinlandPacinolSchering-Plough Europe
- United KingdomFluphenazine 1mg tabletsSpecial Order
- CanadaFLUPHENAZINEAA PHARMA INC
- Japanフルフェナジンデカン酸エステル田辺ファーマ
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Croatia · Moditen
- Slovenia · Moditen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/adfb1502-955a-415b-9204-4c31e54538f6 GET /v1/drugs/adfb1502-955a-415b-9204-4c31e54538f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "10",
"substance": "FLUPHENAZINE HYDROCHLORIDE",
"productndc": "0527-1791",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA089743",
"marketing_category": "ANDA"
}See everything about fluphenazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.